Marusić M - Search Results

1

AgNORs predictive value of prognosis in non-Hodgkin's lymphoma: comparison with flow cytometric cell cycle analysis.

Jakić-Razumović J, Uzarević B, Petrovecki M, Marusić M, Radman I, Labar B. Jakić-Razumović J, et al. Among authors: marusic m. Leuk Lymphoma. 1992 May;7(1-2):165-70. doi: 10.3109/10428199209053618. Leuk Lymphoma. 1992. PMID: 1472929

2

Prognostic significance of cell cycle parameters in infiltrative ductal breast carcinoma.

Uzarević B, Petrovecki M, Marusić M, Jakić-Razumović J, Hutinec Z, Sabioncello A, Gamulin S. Uzarević B, et al. Among authors: marusic m. J Clin Lab Anal. 1998;12(3):131-6. doi: 10.1002/(SICI)1098-2825(1998)12:3<131::AID-JCLA1>3.0.CO;2-C. J Clin Lab Anal. 1998. PMID: 9591698 Free PMC article.

3

Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.

Vucković J, Forenpoher G, Marusić M, UZarević B, Zemunik T. Vucković J, et al. Among authors: marusic m. Neoplasma. 1998;45(5):332-5. Neoplasma. 1998. PMID: 9921923

4

Tumor cell cycle in patients with stage I endometrial carcinoma.

Vecek N, Nola M, Marusić M, Babić D, Uzarević B, Sabioncello A, Petrovecki M, Ljubić-Racunica N, Marinović T. Vecek N, et al. Among authors: marusic m. Gynecol Oncol. 1994 Apr;53(1):38-43. doi: 10.1006/gyno.1994.1084. Gynecol Oncol. 1994. PMID: 8175020

5

Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.

Nola M, Jukić S, Ilić-Forko J, Babić D, Uzarević B, Petrovecki M, Suchanek E, Skrablin S, Dotlić S, Marusić M. Nola M, et al. Among authors: marusic m. Gynecol Oncol. 1999 Mar;72(3):331-6. doi: 10.1006/gyno.1998.5281. Gynecol Oncol. 1999. PMID: 10053103

6

Clinical, histopathological and flow-cytometric properties of incidental renal cell carcinomas.

Katusin D, Uzarević B, Petrovecki M, Mlinac-Lucijanić M, Marusić M, Mareković Z. Katusin D, et al. Among authors: marusic m. Urol Res. 2000 Jan;28(1):52-6. doi: 10.1007/s002400050010. Urol Res. 2000. PMID: 10732696

7

Prognostic significance of cytochemical analysis of leukemic M2 blasts.

Suĭć M, Boban D, Marković-Glamocak M, Petrovecki M, Marusić M, Labar B. Suĭć M, et al. Among authors: marusic m. Med Oncol Tumor Pharmacother. 1992;9(1):41-5. doi: 10.1007/BF02989652. Med Oncol Tumor Pharmacother. 1992. PMID: 1341319

8

Leukocyte membrane markers on cell populations defined by six flow cytometric bitmaps.

Uzarević B, Batinić D, Petrovecki M, Marusić M. Uzarević B, et al. Among authors: marusic m. J Clin Lab Anal. 1992;6(1):17-23. doi: 10.1002/jcla.1860060105. J Clin Lab Anal. 1992. PMID: 1542079

9

T cell subset composition in remission phase of systemic connective tissue diseases.

Markeljević J, Marusić M, Uzarević B, Petrovecki M, Trutin-Ostović K, Cikes N, Batinić D, Babic-Naglic D, Horvat Z. Markeljević J, et al. Among authors: marusic m. J Clin Lab Immunol. 1991 May;35(1):33-9. J Clin Lab Immunol. 1991. PMID: 1668288

10

Natural killer cell number and activity in remission phase of systemic connective tissue diseases.

Markeljević J, Marusić M, Uzarević B, Petrovecki M, Cikes N, Babić-Naglić D, Horvat Z. Markeljević J, et al. Among authors: marusic m. J Clin Lab Immunol. 1991 Jul;35(3):133-8. J Clin Lab Immunol. 1991. PMID: 1668766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters